Business Wire

CA-FORTANIX-INC

10.10.2023 09:01:32 CEST | Business Wire | Press release

Share
Fortanix Introduces New Data Sovereignty Solutions To Help Organizations Meet Evolving Global Data Security and Privacy Requirements

Fortanix® Inc., the data security company and pioneer of Confidential Computing, today announced new capabilities for Fortanix Data Security Manager (DSM) to help public and private organizations address growing data sovereignty requirements globally. Available now, the existing and new features deliver several key capabilities, including support for sovereign cloud, storing keys in sovereign boundaries, anonymization of private data, centralized control to manage access and enforce consistent policies across hybrid and multicloud environments, and more, all delivered via an intuitive user experience.

Organizations around the globe are taking urgent steps to meet strict, complex, and changing data sovereignty regulations. According to a Gartner® report, “Particularly in Europe, but also in other regions, governments are becoming increasingly concerned due to tightening privacy and data protection regulations impacting data sovereignty, data control, technological sovereignty and their dependence on foreign cloud infrastructure providers.”*

Complying with multitude of mandates is a major challenge for organizations, but Fortanix makes it easy for them to ensure compliance over sensitive data, while also bolstering security. The Fortanix flagship DSM offering can be provisioned within customers’ sovereign regions, enabling them to have a dedicated solution that meets regulations in their legislative jurisdictions.

“Data sovereignty goes beyond just where data resides; it is a multi-layered approach that encompasses data security, protection, and privacy. Fortanix’s existing and new capabilities exemplify our commitment to expanding and enhancing DSM to deliver the most advanced data security and privacy solution to organizations around the globe,” said Faiyaz Shahpurwala, chief product and strategy officer at Fortanix. “Security and data teams can now maintain greater international and cross-border security, compliance, and control over their data with a unified platform that is powered by confidential computing and validated by the highest industry certifications.”

“Data sovereignty, data privacy and compliance with regulations such as GDPR and Schrems II are an integral part of our work in behavioral research,” said Raj Jagesar, project lead for the Digital Phenotyping Research Program (Behapp) at the University of Groningen in the Netherlands. “With Fortanix DSM's External Key Manager for Google Cloud, we have full control over our encryption keys not just for compliance purposes, but also to mitigate any security risks related to sensitive personal data.”

Fortanix DSM’s key data sovereignty capabilities include:

  • Full control over key generation and lifecycle management for hybrid, multicloud environments with natively integrated KMS and FIPS 140-2 Level 3 HSM
  • The ability to store encryption keys separate from data and within sovereign regions
  • Enforced least privileged data access with RBAC and Quorum Controls to support Zero Trust architecture
  • Crypto agility with rapid migration to latest approved quantum-proof cryptographic algorithms
  • Format-preserving encryption to anonymize sensitive data at ingestion or creation before sharing across pipelines and workflows to keep it private, usable, and compliant
  • Native database encryption to manage and store the keys required to encrypt all databases, including Oracle, SQL Server, MongoDB, PostGres, MySQL, Maria DB, IBM DB2, and more
  • Joint VMware and Fortanix solution for scalable data protection and compliance for VMware Sovereign cloud environments
  • Sovereign support for Google Cloud services/offerings in the Kingdom of Saudi Arabia, in partnership with SITE and CNTXT
  • Confidential data search, enabling users to quickly search for regulated data in encrypted databases at terabyte scale
  • Customer choice of deployment models: on-premises, virtual appliances running in private or public cloud, or a fully managed SaaS across multiple global regions

Fortanix Expands Client-Side Encryption to Gmail

Fortanix has added support for client-side encryption of Gmail messages, rounding out its offering as an external key manager for organizations working in the Google Workspace ecosystem. This means that data will never be sent from a knowledge worker end point such as an employee laptop without it being encrypted while in transit, boosting data privacy and security across the organization.

Fortanix now offers key management for all Google Workspace applications that use client-side encryption, including Docs, Sheets, Calendar, and now Gmail. This enables Fortanix customers who use Google Workspace to create, store, and manage encryption keys themselves, and not through Google.

Meet with Fortanix at it-sa Expo&Congress 2023

Fortanix will once again have a presence at it-sa Expo&Congress 2023, Europe's largest trade event for IT security. The event takes place Oct. 10-12 at Exhibition Centre Nuremberg in Nuremberg, Germany. Fortanix team members will be on hand in Hall 7, booth number 7-627.

For more information and to purchase tickets, visit the it-sa Expo&Congress website.

Additional Resources

About Fortanix

Fortanix secures data, wherever it is. Fortanix’s data-first approach helps businesses of all sizes to modernize their security solutions on-premises, in the cloud, and everywhere in between. Enterprises worldwide, especially in privacy-sensitive industries like healthcare, fintech, financial services, government, and retail, trust Fortanix for data security, privacy and compliance. Fortanix investors include Goldman Sachs, Foundation Capital, Intel Capital, In-Q-Tel, Neotribe Ventures and GiantLeap Capital. Fortanix is headquartered in Santa Clara, CA. For more information, visit https://www.fortanix.com.

*Gartner, What Are the Different Provider Approaches to ‘Sovereign Cloud’ Demands?, Rene Buest, Gregor Petri, Neville Cannon, Bart Willemsen, 4 April 2022

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231010355406/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release

SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release

Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a

Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release

Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release

GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc

Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release

Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye